DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Landewé R, Sieper J, Mease P. et al.
Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study.
Lancet 2018;
392: 134-144
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.